4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-030447
Chief Legal Officer sold 7,543 shares at $0.72 ($5,431)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew Chief Legal Officer | 2023-05-16 | Sale | −7,543 | $0.72 | $5,431 | 257,680 | D |
| Open-market sales · 7,543 sh · avg $0.72 · $5,431 | |||||||
Loading xslF345X04/doc4.xml…